Taken together, several METTL genes, including METTL1, METTL2A, METTL4, EEF1AKNMT, and METTL24, had relatively higher frequencies of genetic amplification, deletion, or mutation in various tumor types, notably LUAD, BRCA, and GBM. This evidence concerns the gene METTL24 and glioblastoma.